Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos)

Takeshi Ogura, Mamoru Takenaka, Hideyuki Shiomi, Daisuke Goto, Takashi Tamura, Takeshi Hisa, Hironari Kato, Nobu Nishioka, Kosuke Minaga, Atsuhiro Masuda, Takumi Onoyama, Masatoshi Kudo, Kazuhide Higuchi, Masayuki Kitano

Research output: Contribution to journalArticle

Abstract

Background and Objectives: Biliary drainage (BD) under EUS guidance is usually indicated for malignant biliary obstruction. Recently, EUS-guided transluminal treatment has been applied to benign biliary disease (BBD). This multicenter retrospective study evaluated the clinical impact of EUS-guided transluminal stent deployment for BBD with long-term follow-up. Patients and Methods: This retrospective study investigated patients treated between September 2015 and October 2016 at participating hospitals in the therapeutic endoscopic group. The inclusion criteria comprised complications with BBD obstructive jaundice or cholangitis and failed endoscopic retrograde cholangiopancreatography or inaccessible ampulla of Vater. Results: Twenty-six patients underwent EUS-guided transluminal stent deployment. Indications for EUS-guided transluminal stent deployment comprised anastomotic biliary stricture (n = 17), bile duct stones (n = 5), inflammatory biliary stricture (n = 3), and acute pancreatitis prevention (n = 1). Thirteen of these 26 patients underwent scheduled reintervention, with technical success achieved in all 13 patients. None of the deployed stents became dysfunctional. Among the 13 patients who underwent reintervention on demand, stents had become dysfunctional in six patients (stent patency: 48, 90, 172, 288, 289, and 608 days). Reintervention was successfully performed in all patients. During follow-up (median, 749 days), severe adverse events were not seen in any patients. Conclusion: We concluded that EUS-guided transluminal stent deployment for BBD is feasible and safe. Because metal stent dysfunction was more frequent when deployed on demand, such stents should be exchanged for plastic stents in a scheduled manner if a metal stent is used.

Original languageEnglish
Pages (from-to)398-403
Number of pages6
JournalEndoscopic Ultrasound
Volume8
Issue number6
DOIs
Publication statusPublished - Nov 1 2019

Fingerprint

Stents
Pathologic Constriction
Retrospective Studies
Metals
Ampulla of Vater
Cholangitis
Obstructive Jaundice
Endoscopic Retrograde Cholangiopancreatography
Bile Ducts
Pancreatitis
Plastics
Multicenter Studies
Drainage
Therapeutics

Keywords

  • Benign disease
  • EUS
  • EUS biliary drainage
  • EUS hepaticogastrostomy
  • EUS-guided biliary drainage

ASJC Scopus subject areas

  • Hepatology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease : Multicenter clinical experience (with videos). / Ogura, Takeshi; Takenaka, Mamoru; Shiomi, Hideyuki; Goto, Daisuke; Tamura, Takashi; Hisa, Takeshi; Kato, Hironari; Nishioka, Nobu; Minaga, Kosuke; Masuda, Atsuhiro; Onoyama, Takumi; Kudo, Masatoshi; Higuchi, Kazuhide; Kitano, Masayuki.

In: Endoscopic Ultrasound, Vol. 8, No. 6, 01.11.2019, p. 398-403.

Research output: Contribution to journalArticle

Ogura, T, Takenaka, M, Shiomi, H, Goto, D, Tamura, T, Hisa, T, Kato, H, Nishioka, N, Minaga, K, Masuda, A, Onoyama, T, Kudo, M, Higuchi, K & Kitano, M 2019, 'Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos)', Endoscopic Ultrasound, vol. 8, no. 6, pp. 398-403. https://doi.org/10.4103/eus.eus_45_19
Ogura, Takeshi ; Takenaka, Mamoru ; Shiomi, Hideyuki ; Goto, Daisuke ; Tamura, Takashi ; Hisa, Takeshi ; Kato, Hironari ; Nishioka, Nobu ; Minaga, Kosuke ; Masuda, Atsuhiro ; Onoyama, Takumi ; Kudo, Masatoshi ; Higuchi, Kazuhide ; Kitano, Masayuki. / Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease : Multicenter clinical experience (with videos). In: Endoscopic Ultrasound. 2019 ; Vol. 8, No. 6. pp. 398-403.
@article{8c07db60ba4840f887ca961952ac4286,
title = "Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos)",
abstract = "Background and Objectives: Biliary drainage (BD) under EUS guidance is usually indicated for malignant biliary obstruction. Recently, EUS-guided transluminal treatment has been applied to benign biliary disease (BBD). This multicenter retrospective study evaluated the clinical impact of EUS-guided transluminal stent deployment for BBD with long-term follow-up. Patients and Methods: This retrospective study investigated patients treated between September 2015 and October 2016 at participating hospitals in the therapeutic endoscopic group. The inclusion criteria comprised complications with BBD obstructive jaundice or cholangitis and failed endoscopic retrograde cholangiopancreatography or inaccessible ampulla of Vater. Results: Twenty-six patients underwent EUS-guided transluminal stent deployment. Indications for EUS-guided transluminal stent deployment comprised anastomotic biliary stricture (n = 17), bile duct stones (n = 5), inflammatory biliary stricture (n = 3), and acute pancreatitis prevention (n = 1). Thirteen of these 26 patients underwent scheduled reintervention, with technical success achieved in all 13 patients. None of the deployed stents became dysfunctional. Among the 13 patients who underwent reintervention on demand, stents had become dysfunctional in six patients (stent patency: 48, 90, 172, 288, 289, and 608 days). Reintervention was successfully performed in all patients. During follow-up (median, 749 days), severe adverse events were not seen in any patients. Conclusion: We concluded that EUS-guided transluminal stent deployment for BBD is feasible and safe. Because metal stent dysfunction was more frequent when deployed on demand, such stents should be exchanged for plastic stents in a scheduled manner if a metal stent is used.",
keywords = "Benign disease, EUS, EUS biliary drainage, EUS hepaticogastrostomy, EUS-guided biliary drainage",
author = "Takeshi Ogura and Mamoru Takenaka and Hideyuki Shiomi and Daisuke Goto and Takashi Tamura and Takeshi Hisa and Hironari Kato and Nobu Nishioka and Kosuke Minaga and Atsuhiro Masuda and Takumi Onoyama and Masatoshi Kudo and Kazuhide Higuchi and Masayuki Kitano",
year = "2019",
month = "11",
day = "1",
doi = "10.4103/eus.eus_45_19",
language = "English",
volume = "8",
pages = "398--403",
journal = "Endoscopic Ultrasound",
issn = "2303-9027",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "6",

}

TY - JOUR

T1 - Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease

T2 - Multicenter clinical experience (with videos)

AU - Ogura, Takeshi

AU - Takenaka, Mamoru

AU - Shiomi, Hideyuki

AU - Goto, Daisuke

AU - Tamura, Takashi

AU - Hisa, Takeshi

AU - Kato, Hironari

AU - Nishioka, Nobu

AU - Minaga, Kosuke

AU - Masuda, Atsuhiro

AU - Onoyama, Takumi

AU - Kudo, Masatoshi

AU - Higuchi, Kazuhide

AU - Kitano, Masayuki

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Background and Objectives: Biliary drainage (BD) under EUS guidance is usually indicated for malignant biliary obstruction. Recently, EUS-guided transluminal treatment has been applied to benign biliary disease (BBD). This multicenter retrospective study evaluated the clinical impact of EUS-guided transluminal stent deployment for BBD with long-term follow-up. Patients and Methods: This retrospective study investigated patients treated between September 2015 and October 2016 at participating hospitals in the therapeutic endoscopic group. The inclusion criteria comprised complications with BBD obstructive jaundice or cholangitis and failed endoscopic retrograde cholangiopancreatography or inaccessible ampulla of Vater. Results: Twenty-six patients underwent EUS-guided transluminal stent deployment. Indications for EUS-guided transluminal stent deployment comprised anastomotic biliary stricture (n = 17), bile duct stones (n = 5), inflammatory biliary stricture (n = 3), and acute pancreatitis prevention (n = 1). Thirteen of these 26 patients underwent scheduled reintervention, with technical success achieved in all 13 patients. None of the deployed stents became dysfunctional. Among the 13 patients who underwent reintervention on demand, stents had become dysfunctional in six patients (stent patency: 48, 90, 172, 288, 289, and 608 days). Reintervention was successfully performed in all patients. During follow-up (median, 749 days), severe adverse events were not seen in any patients. Conclusion: We concluded that EUS-guided transluminal stent deployment for BBD is feasible and safe. Because metal stent dysfunction was more frequent when deployed on demand, such stents should be exchanged for plastic stents in a scheduled manner if a metal stent is used.

AB - Background and Objectives: Biliary drainage (BD) under EUS guidance is usually indicated for malignant biliary obstruction. Recently, EUS-guided transluminal treatment has been applied to benign biliary disease (BBD). This multicenter retrospective study evaluated the clinical impact of EUS-guided transluminal stent deployment for BBD with long-term follow-up. Patients and Methods: This retrospective study investigated patients treated between September 2015 and October 2016 at participating hospitals in the therapeutic endoscopic group. The inclusion criteria comprised complications with BBD obstructive jaundice or cholangitis and failed endoscopic retrograde cholangiopancreatography or inaccessible ampulla of Vater. Results: Twenty-six patients underwent EUS-guided transluminal stent deployment. Indications for EUS-guided transluminal stent deployment comprised anastomotic biliary stricture (n = 17), bile duct stones (n = 5), inflammatory biliary stricture (n = 3), and acute pancreatitis prevention (n = 1). Thirteen of these 26 patients underwent scheduled reintervention, with technical success achieved in all 13 patients. None of the deployed stents became dysfunctional. Among the 13 patients who underwent reintervention on demand, stents had become dysfunctional in six patients (stent patency: 48, 90, 172, 288, 289, and 608 days). Reintervention was successfully performed in all patients. During follow-up (median, 749 days), severe adverse events were not seen in any patients. Conclusion: We concluded that EUS-guided transluminal stent deployment for BBD is feasible and safe. Because metal stent dysfunction was more frequent when deployed on demand, such stents should be exchanged for plastic stents in a scheduled manner if a metal stent is used.

KW - Benign disease

KW - EUS

KW - EUS biliary drainage

KW - EUS hepaticogastrostomy

KW - EUS-guided biliary drainage

UR - http://www.scopus.com/inward/record.url?scp=85077253496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077253496&partnerID=8YFLogxK

U2 - 10.4103/eus.eus_45_19

DO - 10.4103/eus.eus_45_19

M3 - Article

AN - SCOPUS:85077253496

VL - 8

SP - 398

EP - 403

JO - Endoscopic Ultrasound

JF - Endoscopic Ultrasound

SN - 2303-9027

IS - 6

ER -